RETROVIRUSES AND DNA - GENE-THERAPY FOR BRAIN-TUMORS

被引:9
作者
BROWN, JY
SALEH, M
机构
[1] UNIV MELBOURNE,ROYAL MELBOURNE HOSP,NEUROSCI RES LAB,PARKVILLE,VIC 3050,AUSTRALIA
[2] UNIV MELBOURNE,ROYAL MELBOURNE HOSP,DEPT SURG NEUROSURG,PARKVILLE,VIC 3050,AUSTRALIA
关键词
GLIOMAS; RETROVIRUS; GENE THERAPY; BRAIN TUMOR;
D O I
10.1016/0967-5868(95)90024-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Gene therapy is a revolutionary new approach to the treatment of cancer, with potential use as an adjuvant and possibly even primary therapy for malignant brain tumours, Retroviral vector mediated transfer is the first mechanism for the introduction of foreign genes into target cells that is efficient, selective and safe enough to warrant the development of clinical therapeutic protocols in humans, Expression of the transduced herpes simplex thymidine kinase gene in glioma cells renders them highly sensitive to the toxic effects of ganciclovir, This gene has been transduced into central nervous system (CNS) tumours in vivo resulting in significant tumour cell death and in some cases, complete tumour eradication, Formidable technical obstacles still remain to be overcome before gene therapy can be generally accepted as a treatment modality, If the development of gene therapy on both a technological and commercial level continues at the current exponential rate then it is surely only a matter of time before these hurdles are overcome.
引用
收藏
页码:16 / 23
页数:8
相关论文
共 50 条
[21]  
Ram, Culver, Walbridge, Blaese, Oldfield, In situ retroviral mediated gene transfer for the treatment of brain tumours in rats, Cancer Res, 53, pp. 83-88, (1993)
[22]  
Anderson, Editorial gene therapy for cancer, Human Gene Therapy, 5, pp. 1-2, (1994)
[23]  
Boris-Lawrie, Temin, Recent advances in retrovirus vector technology, Current Opinion in Genetics and Development, 3, pp. 102-109, (1993)
[24]  
Vile, Hart, Use of tissue specific expression of the Herpes thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoural injection of DNA, Cancer Res, 53, pp. 3860-3864, (1993)
[25]  
Culver, Ram, Walbridge, Ishii, Oldfield, Blaese, In vivo gene transfer with retroviral vector-producer cells for the treatment of experimental brain tumours, Science, 256, pp. 1550-1552, (1992)
[26]  
Takamiya, Short, Moolten, Et al., An experimental model of retrovirus gene therapy for malignant brain tumours, J Neurosurg, 79, pp. 104-110, (1993)
[27]  
Barba, Hardin, Ray, Gage, Thymidine kinase mediated killing of rat brain tumours, J Neurosurg, 79, pp. 729-735, (1993)
[28]  
Ledley, Are contemporary methods for somatic gene therapy suitable for clinical applications?, Clin Invest Med, 16, pp. 78-88, (1993)
[29]  
Stone, Molecular ‘surgery’ for brain tumours, Science, 256, (1992)
[30]  
Seachrist, Successful gene therapy has researchers looking for the bystander effect, J Natl Cancer Inst, 86, pp. 82-83, (1994)